sc13g

0000950134-07-024609.txt : 20071129 0000950134-07-024609.hdr.sgml : 20071129 20071128181325 ACCESSION NUMBER: 0000950134-07-024609 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20071129 DATE AS OF CHANGE: 20071128 GROUP MEMBERS: MARK L HART III SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AspenBio Pharma, Inc. CENTRAL INDEX KEY: 0001167419 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 841553387 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79102 FILM NUMBER: 071272619 BUSINESS ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 BUSINESS PHONE: (303) 794-2000 MAIL ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 FORMER COMPANY: FORMER CONFORMED NAME: ASPENBIO INC DATE OF NAME CHANGE: 20020213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Corriente Advisors, LLC CENTRAL INDEX KEY: 0001406718 IRS NUMBER: 752939516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 201 MAIN STREET STREET 2: SUITE 1800 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 8178700400 MAIL ADDRESS: STREET 1: 201 MAIN STREET STREET 2: SUITE 1800 CITY: FORT WORTH STATE: TX ZIP: 76102 SC 13G 1 d51881sc13g.htm SCHEDULE 13G sc13g

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. ___)*

AspenBio Pharma, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

045346103

(CUSIP Number)

November 27, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


				Rule 13d-1(b)
		þ		Rule 13d-1(c)
				Rule 13d-1(d)

^* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.		045346103


1	Names of Reporting Persons. Corriente Advisors, LLC I.R.S. Identification Nos. of above persons (entities only).


2	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a) o
	(b) þ

3	SEC Use Only



4	Citizenship or Place of Organization

	Delaware

		5	Sole Voting Power

Number of			1,628,199

Shares		6	Shared Voting Power
Beneficially
Owned by			0

Each		7	Sole Dispositive Power
Reporting
Person			1,628,199

With:		8	Shared Dispositive Power

			0

9	Aggregate Amount Beneficially Owned by Each Reporting Person

	1,628,199

10	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

	o

11	Percent of Class Represented by Amount in Row (9)

	5.8%

12	Type of Reporting Person (See Instructions)

	OO/IA


CUSIP No.		045346103


1	Names of Reporting Persons. Mark L. Hart III I.R.S. Identification Nos. of above persons (entities only).


2	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a) o
	(b) þ

3	SEC Use Only



4	Citizenship or Place of Organization

	United States

		5	Sole Voting Power

Number of			1,628,199

Shares		6	Shared Voting Power
Beneficially
Owned by			0

Each		7	Sole Dispositive Power
Reporting
Person			1,628,199

With:		8	Shared Dispositive Power

			0

9	Aggregate Amount Beneficially Owned by Each Reporting Person

	1,628,199

10	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

	o

11	Percent of Class Represented by Amount in Row (9)

	5.8%

12	Type of Reporting Person (See Instructions)

	IN/HC

TABLE OF CONTENTS


	Item 1
	Item 2
	Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:
	Item 4. Ownership
	Item 5. Ownership of 5% or Less of a Class
	Item 6. Ownership of More than 5 Percent on Behalf of Another Person
	Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
	Item 8. Identification and Classification of Members of the Group
	Item 9. Notice of Dissolution of Group
	Item 10. Certifications
SIGNATURE
EXHIBIT INDEX
Joint Filing Agreement

Item 1.

(a) Name of Issuer

AspenBio Pharma, Inc.

(b) Address of Issuer’s Principal Executive Offices

1585 South Perry Street, Castle Rock, Colorado 80104

Item 2.

(a) Name of Person Filing

This statement is jointly filed by and on behalf of each of Corriente Advisors, LLC and Mark L. Hart III. Corriente Advisors acts as an investment adviser to, and manages investment and trading accounts of, other persons, including Corriente Master Fund, L.P. Corriente Advisors may be deemed, through investment advisory contracts or otherwise, to beneficially own securities owned by other persons, including Corriente Master Fund. Mr. Hart is the Chairman and Chief Executive Officer of Corriente Advisors and may be deemed to control Corriente Advisors and beneficially own securities owned by Corriente Advisors.

Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act) with any other person as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any syndicate or group with respect to the issuer or any securities of the issuer.

(b) Address of Principal Business Office or, if none, Residence

The address of the principal business office of each reporting person is 201 Main Street, Suite 1800, Fort Worth, Texas 76102.

(c) Citizenship

See Item 4 on the cover page(s) hereto.

(d) Title of Class of Securities

Common Stock

(e) CUSIP Number

045346103

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

(a) o		A Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

(b) o		A Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) o		An insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) o		An investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) o		An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f) o		An employee benefit plan or endowment fund in accordance with §240.13d- 1(b)(1)(ii)(F);

(g) o		A parent holding company or control person in accordance with §240.13d- 1(b)(1)(ii)(G);

(h) o		A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) o		A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) o		A group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership.

(a) Amount beneficially owned:

See Item 9 on the cover page(s) hereto.

(b) Percent of class:

See Item 11 on the cover page(s) hereto.

(c) Number of shares as to which such person has:

(i) Sole power to vote or to direct the vote:

See Item 5 on the cover page(s) hereto.

(ii) Shared power to vote or to direct the vote:

See Item 6 on the cover page(s) hereto.

(iii) Sole power to dispose or to direct the disposition of:

See Item 7 on the cover page(s) hereto.

(iv) Shared power to dispose or to direct the disposition of:

See Item 8 on the cover page(s) hereto.

Item 5. Ownership of 5% or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6. Ownership of More than 5 Percent on Behalf of Another Person

Corriente Master Fund, L.P. is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities covered by this statement that may be deemed to be beneficially owned by the reporting persons.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8. Identification and Classification of Members of the Group

Item 9. Notice of Dissolution of Group

Item 10. Certifications

(a) Not Applicable

(b) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Date: November 28, 2007	CORRIENTE ADVISORS, LLC

	By: Name:	/s/ James E. Haddaway James E. Haddaway
	Title:	Chief Financial Officer and Chief Operating Officer

	MARK L. HART III

	By:	/s/ Mark L. Hart III

	Name:	Mark L. Hart III

EXHIBIT INDEX


Exhibit		Description of Exhibit
99.1		Joint Filing Agreement

EX-99.1 2 d51881exv99w1.htm JOINT FILING AGREEMENT exv99w1

EXHIBIT 99.1

JOINT FILING AGREEMENT

November 28, 2007

Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Exchange Act or any rule or regulation thereunder (including any amendment, supplement, and/or exhibit thereto) with the Securities and Exchange Commission (and, if such security is registered on a national securities exchange, also with the exchange), and further agrees to the filing, furnishing, and/or incorporation by reference of this Joint Filing Agreement as an exhibit thereto. This Joint Filing Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party.

IN WITNESS WHEREOF, each party hereto, being duly authorized, has caused this Joint Filing Agreement to be executed and effective as of the date first written above.


Date: November 28, 2007	CORRIENTE ADVISORS, LLC

	By: Name:	/s/ James E. Haddaway James E. Haddaway
	Title:	Chief Financial Officer and Chief Operating Officer

	MARK L. HART III

	By:	/s/ Mark L. Hart III

	Name:	Mark L. Hart III

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents